Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

4 Jan 2023 07:10

RNS Number : 6310L
Compagnie de Saint-Gobain
04 January 2023
 

 

 

 

 

SAINT-GOBAIN STRENGTHENS its presence in construction chemicals, with the acquisitions of

matchem in brazil and IDP Chemicals in egypt

 

Saint-Gobain, through its Chryso business, has completed the acquisition of Matchem in Brazil and entered into exclusive negotiations to acquire IDP Chemicals in Egypt.

 

The acquisitions of Matchem and IDP Chemicals will allow Saint-Gobain to strengthen its position in construction chemicals, in particular concrete admixtures which play a key role in the decarbonization of the construction industry. These two companies are focused on the buoyant building and infrastructure markets in Brazil and Egypt, which should see strong growth for the years to come.

 

Matchem, established in 2011, employs around 50 people across two plants in Brazil and generated revenues of close to €20 million in 2022. Together with Quartzolit, leader in mortars (tile fixings, wall and floor coatings, waterproofing membranes), TekBond, sealant and adhesive specialist, and the recently acquired GCP Applied Technologies, Matchem will reinforce Saint-Gobain's platform in construction chemicals, a leader on the Brazilian market with 24 industrial sites.

 

IDP Chemicals, licensed by Chryso since 2018, employs 25 people at one plant and is well positioned to serve the dynamic construction market in Egypt. This acquisition should be finalized in the first quarter of 2023.

 

Chryso benefits from Saint-Gobain's strong presence in Brazil and Egypt to accelerate its inorganic growth strategy. Matchem and IDP Chemicals will be consolidated within the Construction Chemicals segment in High Performance Solutions.

 

The acquisitions of Matchem and IDP Chemicals are in line with Saint-Gobain's "Grow & Impact" strategy aiming to both strengthen the Group's leadership and accelerate its growth by enriching its range of solutions for light and sustainable construction.

 

 

ABOUT SAINT-GOBAIN

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufacturesand distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonizationof construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group's commitment is guided by its purpose,"MAKING THE WORLD A BETTER HOME".

 

€44.2 billion in sales in 2021

166,000 employees, locations in 76 countries

Committed to achieving Carbon Neutrality by 2050

 

For more information about Saint-Gobain,visit www.saint-gobain.com and follow us on Twitter @saintgobain

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBIMRTMTMMMFJ
Date   Source Headline
24th Nov 20225:08 pmRNSPower purchase agreement
27th Oct 20225:08 pmRNS3rd Quarter Results
25th Oct 20225:07 pmRNSPower Purchase Agreement
28th Sep 20227:05 amRNSPartnership between Saint-Gobain and Megasol
22nd Sep 20227:33 amRNSAcquisition
21st Sep 20225:13 pmRNSCSR Roadmap
15th Sep 20225:20 pmRNSPower Purchase Agreement
12th Sep 20224:06 pmRNSStabilisation Notice - CSG TRIPLE
2nd Sep 202211:25 amRNSSaint-Gobain's commitments to reduce its CO2 emiss
2nd Sep 20227:31 amRNSDisposal
1st Sep 20225:47 pmRNSDisposal
3rd Aug 20224:36 pmRNSPrice Monitoring Extension
3rd Aug 20228:59 amRNSStabilisation Notice- COMPAGNIE DE SAINT-GOBAIN
3rd Aug 20227:00 amRNSIssue of Debt
2nd Aug 20228:55 amRNSStabilisation Notice - COMPAGNIE DE SAINT-GOBAIN
1st Aug 20227:10 amRNSAcquisition
28th Jul 20225:03 pmRNSHalf-year Report
26th Jul 20224:42 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
25th Jul 20224:43 pmRNSSecond Price Monitoring Extn
25th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:11 amRNSDisposal
10th Jun 20225:05 pmRNSCapital reduction
9th Jun 20225:44 pmRNSNew plant
6th Jun 20227:00 amRNSGeneral Shareholders' Meeting
6th Jun 20227:00 amRNSTrading Statement
1st Jun 20227:00 amRNSAcquisition
27th May 20227:09 amRNSDisposal
24th May 20225:09 pmRNSAcquisition
16th May 202212:58 pmRNSResults of the tender offer launched on May 6,2022
16th May 20227:08 amRNSZero-carbon production of flat glass
12th May 20226:20 pmRNSAcquisition
12th May 20223:12 pmRNSDisposal
6th May 20229:38 amRNSTender offer for bonds
28th Apr 20224:54 pmRNS1st Quarter Results
25th Apr 20227:07 amRNSAgreement
5th Apr 20225:08 pmRNSDisposal
25th Mar 20227:08 amRNSAppointments
9th Mar 20227:08 amRNSNew capacity production
24th Feb 20225:18 pmRNS2021 Annual Results
17th Feb 20225:10 pmRNSDisposal
4th Feb 20227:05 amRNSDisposal
21st Dec 20215:04 pmRNSAcquisition
13th Dec 20215:06 pmRNSDisposal
10th Dec 20217:06 amRNSDisposal
8th Dec 20217:08 amRNSSaint-Gobain once again included in the CDP A List
6th Dec 20217:00 amRNSAcquisition
1st Dec 20217:00 amRNSShare buy back
25th Nov 20215:49 pmRNSNew director
15th Nov 20217:04 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.